Lexology August 21, 2024
The prospects and expectations of AI patents
A convincing 66% of IP-industry panelists agreed or strongly agreed that the use of AI in drug discovery will increase the patenting of drug candidates generated by computer models. It is clear that such automated processes are neither an “if” nor a “when” but a “now.” The expanded efficiency they bring to an industry facing skill shortages and supply chain issues is non-optional — but with this advantage comes new hurdles.
It is no surprise then that 69% said AI will result in IP challenges related to data ownership, and 60% anticipate challenges in identifying true inventors. This indicates that AI is expected to complicate the understanding of IP ownership and accreditation, adding...
Today's Sponsors
Today's Sponsor